CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to ARWR

ARO-DUX4 for Injection

Phase 2
Arrowhead Pharmaceuticals, Inc. (ARWR)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Facio-Scapulo-Humeral Dystrophy

View Full Landscape
Drug Information

Target Indication

Facio-Scapulo-Humeral Dystrophy

Clinical Trial

NCT06131983

Last updated: 1/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.